Rezultati - Thomas Powles

Refine Results
  1. 1
    Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer

    Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer od Thomas Powles

    Izdano 2020
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic

    Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic od Silke Gillessen, Thomas Powles

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now

    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now od J Bellmunt, Thomas Powles, Nicholas J. Vogelzang

    Izdano 2017
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma

    The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma od Thomas Powles, Jill Walker, J. Andrew Williams, Joaquim Bellmunt

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    The cancer-immunity cycle: Indication, genotype, and immunotype

    The cancer-immunity cycle: Indication, genotype, and immunotype od Ira Mellman, Daniel S. Chen, Thomas Powles, Shannon J. Turley

    Izdano 2023
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial

    Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial od Darren R. Feldman, Robert Huddart, Emma Hall, J. Beyer, Thomas Powles

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma od Robert J. Motzer, Bernard Escudier, Thomas Powles, Christian Scheffold, Toni K. Choueiri

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Rise of Antibody-Drug Conjugates: The Present and Future

    Rise of Antibody-Drug Conjugates: The Present and Future od Mythili Shastry, Avantika Gupta, Sarat Chandarlapaty, Matthew R. Young, Thomas Powles, Erika Hamilton

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis

    The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis od Thomas Powles, David Robinson, Jonathan Shamash, Henrik Møller, N. L. Tranter, R.T.D. Oliver

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches

    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches od Dongkui Song, Thomas Powles, Lei Shi, Lirong Zhang, Molly A. Ingersoll, Yong‐Jie Lu

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events od Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

    Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection od Thomas Powles, David Robinson, Justin Stebbing, Jonathan Shamash, Mark Nelson, Brian Gazzard, Sundhiya Mandelia, Henrik Møller, Mark Bower

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib

    Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib od Jonathan Welti, Morgane Gourlaouen, Thomas Powles, Sakunthala C. Kudahetti, Paul A. Wilson, Daniel M. Berney, Andrew R. Reynolds

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer od Nick van Dijk, Samuel A. Funt, Christian U. Blank, Thomas Powles, Jonathan E. Rosenberg, Michiel S. van der Heijden

    Izdano 2018
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway

    Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway od Thomas Powles, Robert te Poele, Jonathan Shamash, Tracy Chaplin, David Propper, Simon Joel, R.T.D. Oliver, Wai M. Liu

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma od Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Local treatments for metastases of renal cell carcinoma: a systematic review

    Local treatments for metastases of renal cell carcinoma: a systematic review od Saeed Dabestani, Lorenzo Marconi, Fabian Hofmann, Fiona Stewart, Thomas Lam, Steven Canfield, Michael Staehler, Thomas Powles, Börje Ljungberg, Axel Bex

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment

    Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment od Gregory Kaltsas, Thomas Powles, Jane Evanson, P N Plowman, J. E. Drinkwater, P Jenkins, JP Monson, G. M. Besser, Ashley Grossman

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients

    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients od Thomas Powles, Sergio Bracarda, Chen Mei, Elliot Norry, Natalie Compton, Mark Heise, Thomas E. Hutson, Philipp Harter, Christopher L. Carpenter, Lini Pandite, Neil Kaplowitz

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma

    Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma od Jennifer L. Beaumont, John M. Salsman, Jose Diaz, Keith C. Deen, Lauren McCann, Thomas Powles, Michelle D. Hackshaw, Robert J. Motzer, David Cella

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: